Showing results 1 to 20 of 71
next >
| Issue Date | Title | Author(s) |
| 2008 | Adjunctive versus monotherapeutic treatment for schizophrenia : addressing antipsychotic side effects | Hazra, Monica; Mamo, David; Remington, Gary |
| 2007 | Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D 2 receptors : a PET study in schizophrenia | Mizrahi, Romina; Rusjan, Pablo; Agid, Ofer; Graff-Guerrero, Ariel; Mamo, David; Zipursky, Robert B.; Kapur, Shitij |
| 2013 | Alzheimer's disease research group (ADRG) | Scerri, Charles; Ferry, Peter; Scerri, Anthony; Farrugia Bonello, Rosette; Zahra, Anthony; Mamo, David |
| 2010 | Analysis of antipsychotic dose reduction | Uchida, Hiroyuki; Suzuki, Takefumi; Takeuchi, Hiroyoshi; Mamo, David |
| 2008 | The antipsychotic potential of l-stepholidine : a naturally occurring dopamine receptor D1 agonist and D2 antagonist | Natesan, Sridhar; Reckless, Greg E.; Barlow, Karen B. L.; Odontiadis, John; Nobrega, Jose N.; Baker, Glen B.; George, Susan R.; Mamo, David; Kapur, Shitij |
| 2010 | Are antipsychotic prescribing patterns different in older and younger adults? : a survey of 1357 psychiatric inpatients in Toronto | Sproule, Beth A.; Lake, Jennifer; Mamo, David; Uchida, Hiroyuki; Mulsant, Benoit H. |
| 2009 | Benzodiazepine and antidepressant use in elderly patients with anxiety disorders : a survey of 796 outpatients in Japan | Uchida, Hiroyuki; Suzuki, Takefumi; Mamo, David; Mulsant, Benoit H.; Kikuchi, Toshiaki; Takeuchi, Hiroyoshi; Tomita, Masayuki; Watanabe, Koichiro; Yagi, Gohei; Kashima, Haruo |
| 2008 | Brain region binding of the D2/3 agonist [11C]‐(+)‐PHNO and the D2/3 antagonist [11C] raclopride in healthy humans | Graff-Guerrero, Ariel; Willeit, Matthaeus; Ginovart, Nathalie; Mamo, David; Mizrahi, Romina; Rusjan, Pablo; Vitcu, Irina; Seeman, Philip; Wilson, Alan A.; Kapur, Shitij |
| 2012 | Cholinergic pathways and cognition in patients with schizophrenia : a pilot study | Rajji, Tarek K.; Chow, Tiffany W.; Voineskos, Aristotle N.; Links, Kira A.; Miranda, Dielle; Mamo, David; Ismail, Zahinoor; Pollock, Bruce G.; Mulsant, Benoit H. |
| 2010 | Clozapine and global cognition in schizophrenia | Rajji, Tarek K.; Uchida, Hiroyuki; Ismail, Zahinoor; Ng, Wenzie; Mamo, David; Remington, Gary; Pollock, Bruce G.; Mulsant, Benoit H. |
| 2009 | Clozapine exposure and the impact of smoking and gender : a population pharmacokinetic study | Ng, Wenzie; Uchida, Hiroyuki; Ismail, Zahinoor; Mamo, David; Rajji, Tarek K.; Remington, Gary; Sproule, Beth A.; Pollock, Bruce G.; Mulsant, Benoit H.; Bies, Robert R. |
| 2010 | Complementary and alternative medicine in psychotic disorders | Hazra, Monica; Noh, Samuel; Boon, Heather; Taylor, Andree; Moss, Karen; Mamo, David |
| 2009 | D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophrenia | Uchida, Hiroyuki; Rajji, Tarek K.; Mulsant, Benoit H.; Kapur, Shitij; Pollock, Bruce G.; Graff-Guerrero, Ariel; Menon, Mahesh; Mamo, David |
| 2008 | D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography : an open-label study in patients with schizophrenia | Mamo, David; Kapur, Shitij; Keshavan, Matcheri; Laruelle, Marc; Taylor, Cindy C.; Kothare, Prajakti A.; Barsoum, Penny; McDonnell, David |
| 2012 | Defining treatment-resistant schizophrenia and response to antipsychotics : a review and recommendation | Suzuki, Takefumi; Remington, Gary; Mulsant, Benoit H.; Uchida, Hiroyuki; Rajji, Tarek K.; Graff-Guerrero, Ariel; Mimura, Masaru; Mamo, David |
| 2012 | Delineating the functional neuroanatomy of illness denial or anosognosia in schizophrenia | Gerretsen, Philip; Graff-Guerrero, Ariel; Mamo, David; Pollock, Bruce G.; Menon, Mahesh |
| 2007 | Differential effects of aripiprazole on D 2, 5-HT 2, and 5-HT 1A receptor occupancy in patients with schizophrenia : a triple tracer PET study | Mamo, David; Graff-Guerrero, Ariel; Mizrahi, Romina; Shammi, Chekkera M.; Romeyer, Franvoise; Kapur, Shitij |
| 2010 | Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late life | Ting, Christina; Rajji, Tarek K.; Ismail, Zahinoor; Tang-Wai, David F.; Apanasiewicz, Nina; Miranda, Dielle; Mamo, David; Mulsant, Benoit H. |
| 2015 | Dopamine D 2/3 receptor availability in the striatum of antipsychotic-free older patients with schizophrenia : a [11 C]-raclopride PET study | Nakajima, Shinichiro; Caravaggio, Fernando; Mamo, David; Mulsant, Benoit H.; Chung, Jun Ku; Plitman, Eric; Iwata, Yusuke; Gerretsen, Philip; Uchida, Hiroyuki; Suzuki, Takefumi; Mar, Wanna; Wilson, Alan A.; Houle, Sylvain; Graff-Guerrero, Ariel |
| 2015 | Dopamine D 2/3 receptor occupancy following dose reduction is predictable with minimal plasma antipsychotic concentrations : an open-label clinical trial | Nakajima, Shinichiro; Uchida, Hiroyuki; Bies, Robert R.; Caravaggio, Fernando; Suzuki, Takefumi; Plitman, Eric; Mar, Wanna; Gerretsen, Philip; Pollock, Bruce G.; Mulsant, Benoit H.; Mamo, David; Graff-Guerrero, Ariel |
